The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Cetirelief Allergy 10mg Film-coated Tablets



Phoenix LabsPA1113/014/001

Main Information

Trade NameCetirelief Allergy 10mg Film-coated Tablets
Active SubstancesCetirizine dihydrochloride
Dosage FormFilm-coated tablet
Licence HolderPhoenix Labs
Licence NumberPA1113/014/001

Group Information

ATC CodeR06AE Piperazine derivatives
R06AE07 cetirizine

Status

License statusAuthorised
Licence Issued30/06/2006
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of LicenceSupply through pharmacies only and promotion to the public subject to the following restrictions: maximum strength of 10 mg, maximum daily dose of 10 mg and maximum pack size of 30 tablets
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back